This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
Bimatoprost SR administered in the study eye on Day 1, Week 16, and Week 32.
Sham administered on Day 1, Week 16, and Week 32.
Timolol 0.5% administered once in the morning and once in the evening for up to 20 months.
Timolol vehicle administered once in the morning and once in the evening for up to 20 months.
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina
Mar del Plata, Buenos Aires, Argentina
Pilar, Buenos Aires, Argentina
Rosario, Santa Fe Province, Argentina
Rosario, Santa Fe Province, Argentina
Ciudad Autónoma de BuenosAires, Argentina
Mendoza, Argentina